BLASUBCUTANEOUSINJECTABLE
Approved
Mar 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
FOLLISTIM AQ (follitropin) by Merck & Co. is women: follicle-stimulating hormone (fsh), the active component in follistim aq cartridge, is required for normal follicular growth, maturation, and gonadal steroid production. Approved for infertility, ovulation induction, controlled ovarian stimulation and 1 more indications. First approved in 2004.
Drug data last refreshed 18h ago
Mechanism of Action
Women: Follicle-stimulating hormone (FSH), the active component in FOLLISTIM AQ Cartridge, is required for normal follicular growth, maturation, and gonadal steroid production. In women, the level of FSH is critical for the onset and duration of follicular development, and consequently for the…
Pharmacologic Class:
Gonadotropin
Indications (4)
Worked on FOLLISTIM AQ at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.